Valuation: Arcadia Biosciences, Inc.

Market Cap 1.41M 1.23M 1.14M 1.05M 1.99M 134M 2.03M 13.58M 5.33M 66.19M 5.29M 5.17M 228M P/E 2024
-1.15x
P/E 2025 -1.16x
Enterprise Value -3.15M -2.76M -2.54M -2.35M -4.46M -301M -4.53M -30.41M -11.94M -148M -11.84M -11.59M -509M EV / Sales 2024
0.79x
EV / Sales 2025 -0.38x
Free-Float
94.12%
Yield 2024 *
-
Yield 2025 -
1 day+1.39%
1 week-6.56%
Current month+0.85%
1 month-33.50%
3 months-48.11%
6 months-71.81%
Current year-65.41%
1 week 0.65
Extreme 0.6522
0.74
1 month 0.63
Extreme 0.6304
1.06
Current year 0.63
Extreme 0.6304
2.75
1 year 0.63
Extreme 0.6304
6.71
3 years 0.63
Extreme 0.6304
10.31
5 years 0.63
Extreme 0.6304
107.6
10 years 0.63
Extreme 0.6304
2,662.4
Manager TitleAgeSince
Chief Executive Officer 50 2024-07-04
Director TitleAgeSince
Chairman 57 2017-11-21
Director/Board Member 76 2017-06-12
Director/Board Member 58 2017-08-09
Date Insider Type Main position Quantity % Market Cap.
25-05-08Free

Chief Executive Officer

12,500 0.9158%
25-05-08Free

Chief Financial Officer

12,500 0.9158%
25-02-02Buy

Chief Executive Officer

700 0.0513%
Change 5-day change 1-year change 3-year change Capi.($)
+1.39%-6.56%-85.67%-84.47% 1.41M
+2.67%-1.34%-11.76%+9.12% 576M
-2.77%-7.64%-81.31%-96.26% 338M
-0.92%-10.04%+59.85%+63.50% 65.86M
+6.19%-5.32%-35.69%+289.08% 50.95M
Average +1.31%-6.42%-30.92%+36.19% 206.43M
Weighted average by Cap. +0.83%-4.83%-31.26%-8.23%

Financials

2024 2025
Net sales 5.04M 4.41M 4.07M 3.76M 7.13M 481M 7.25M 48.63M 19.1M 237M 18.94M 18.53M 815M 4.86M 4.25M 3.92M 3.62M 6.87M 463M 6.98M 46.83M 18.39M 228M 18.24M 17.84M 785M
Net income -7.04M -6.16M -5.68M -5.24M -9.95M -671M -10.12M -67.85M -26.64M -331M -26.43M -25.85M -1.14B -2.34M -2.05M -1.89M -1.74M -3.31M -223M -3.36M -22.55M -8.85M -110M -8.78M -8.59M -378M
Net Debt -4.09M -3.57M -3.3M -3.05M -5.78M -390M -5.88M -39.4M -15.47M -192M -15.35M -15.01M -660M -4.56M -3.99M -3.68M -3.4M -6.45M -435M -6.56M -43.99M -17.27M -214M -17.13M -16.76M -737M
Logo Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Employees
8
Date Price Change Volume
26-07-10 US$0.6849 +1.39% 45,586
26-07-09 US$0.6755 -1.14% 179,565
26-07-08 US$0.6833 -2.86% 448,770
26-07-07 US$0.7034 -2.32% 30,790

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RKDA Stock